Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-027425

EVP, Research & CSO acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-16 Exercise or conversion : show line 1 in the form +3,500 $1.53 $5,355 91,700 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-16 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −3,500 314,495 D
Loading xslF345X03/doc4.xml…